Wellington – 4 November 2022 - Vertex Pharmaceuticals today announced that it has reached a provisional agreement with New Zealand’s medicines purchasing agency, Pharmac, for the reimbursement ...

Vertex Announces New Portfolio Reimbursement Agreement in Italy Including KAFTRIO®, SYMKEVI® and Additional Indications of ORKAMBI® and KALYDECO® for Eligible Patients With Cystic Fibrosis - ...